↑Takamatsu K, Kobayashi M, Saitoh S, Fujishiro M, Noguchi T (April 1994). "Molecular cloning of human hippocalcin cDNA and chromosomal mapping of its gene". Biochem. Biophys. Res. Commun.200 (1): 606–11. PMID8166736. doi:10.1006/bbrc.1994.1491.
↑Masaki T, Sakai E, Furuta Y, Kobayashi M, Takamatsu K (December 1998). "Genomic structure and chromosomal mapping of the human and mouse hippocalcin genes". Gene225 (1–2): 117–24. PMID9931466. doi:10.1016/S0378-1119(98)00526-5.
Hidaka H, Okazaki K (1993). "Neurocalcin family: a novel calcium-binding protein abundant in bovine central nervous system". Neurosci. Res.16 (2): 73–7. PMID8387172. doi:10.1016/0168-0102(93)90074-Z.
Nagao M, Hayashi H (2009). "Mixed lineage kinase 2 and hippocalcin are localized in Lewy bodies of Parkinson's disease". J. Neurol. Sci.281 (1–2): 51–4. PMID19332348. doi:10.1016/j.jns.2009.02.375.
Kobayashi M, Takamatsu K, Saitoh S, et al. (1992). "Molecular cloning of hippocalcin, a novel calcium-binding protein of the recoverin family exclusively expressed in hippocampus". Biochem. Biophys. Res. Commun.189 (1): 511–7. PMID1280427. doi:10.1016/0006-291X(92)91587-G.
Kobayashi M, Takamatsu K, Saitoh S, Noguchi T (1993). "Myristoylation of hippocalcin is linked to its calcium-dependent membrane association properties". J. Biol. Chem.268 (25): 18898–904. PMID8360179.
Rudinskiy N, Kaneko YA, Beesen AA, et al. (2009). "Diminished hippocalcin expression in Huntington's disease brain does not account for increased striatal neuron vulnerability as assessed in primary neurons". J. Neurochem.111 (2): 460–72. PMID19686238. doi:10.1111/j.1471-4159.2009.06344.x.
O'Callaghan DW, Ivings L, Weiss JL, et al. (2002). "Differential use of myristoyl groups on neuronal calcium sensor proteins as a determinant of spatio-temporal aspects of Ca2+ signal transduction". J. Biol. Chem.277 (16): 14227–37. PMID11836243. doi:10.1074/jbc.M111750200.